Wells Fargo’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-782
Closed -$258 7384
2023
Q1
$258 Buy
782
+1
+0.1% ﹤0.01% 6384
2022
Q4
$562 Buy
781
+2
+0.3% +$1 ﹤0.01% 6026
2022
Q3
$1K Sell
779
-1
-0.1% -$1 ﹤0.01% 6214
2022
Q2
$0 Buy
780
+6
+0.8% ﹤0.01% 7498
2022
Q1
$2K Hold
774
﹤0.01% 6370
2021
Q4
$1K Sell
774
-2,899
-79% -$3.75K ﹤0.01% 6560
2021
Q3
$10K Sell
3,673
-253
-6% -$689 ﹤0.01% 5889
2021
Q2
$12K Sell
3,926
-186
-5% -$569 ﹤0.01% 5763
2021
Q1
$16K Sell
4,112
-8,675
-68% -$33.8K ﹤0.01% 5855
2020
Q4
$45K Sell
12,787
-12,770
-50% -$44.9K ﹤0.01% 5415
2020
Q3
$167K Buy
25,557
+10,925
+75% +$71.4K ﹤0.01% 4868
2020
Q2
$108K Sell
14,632
-9,943
-40% -$73.4K ﹤0.01% 4986
2020
Q1
$116K Sell
24,575
-3,722
-13% -$17.6K ﹤0.01% 4800
2019
Q4
$365K Buy
28,297
+4,961
+21% +$64K ﹤0.01% 4484
2019
Q3
$245K Buy
23,336
+3,823
+20% +$40.1K ﹤0.01% 4674
2019
Q2
$332K Sell
19,513
-7,475
-28% -$127K ﹤0.01% 4513
2019
Q1
$910K Buy
26,988
+9,542
+55% +$322K ﹤0.01% 3904
2018
Q4
$509K Sell
17,446
-2,023
-10% -$59K ﹤0.01% 4206
2018
Q3
$1.2M Buy
19,469
+3,451
+22% +$213K ﹤0.01% 3766
2018
Q2
$1.18M Buy
16,018
+11,933
+292% +$881K ﹤0.01% 3823
2018
Q1
$268K Sell
4,085
-2,338
-36% -$153K ﹤0.01% 4654
2017
Q4
$541K Sell
6,423
-1,077
-14% -$90.7K ﹤0.01% 4237
2017
Q3
$866K Sell
7,500
-607
-7% -$70.1K ﹤0.01% 3884
2017
Q2
$947K Buy
8,107
+499
+7% +$58.3K ﹤0.01% 3708
2017
Q1
$939K Buy
7,608
+3,624
+91% +$447K ﹤0.01% 3736
2016
Q4
$543K Buy
3,984
+2,831
+246% +$386K ﹤0.01% 4040
2016
Q3
$229K Buy
1,153
+713
+162% +$142K ﹤0.01% 4243
2016
Q2
$57K Sell
440
-55
-11% -$7.13K ﹤0.01% 4936
2016
Q1
$46K Buy
495
+52
+12% +$4.83K ﹤0.01% 5052
2015
Q4
$90K Hold
443
﹤0.01% 4804
2015
Q3
$64K Sell
443
-196
-31% -$28.3K ﹤0.01% 4970
2015
Q2
$136K Buy
639
+599
+1,498% +$127K ﹤0.01% 4678
2015
Q1
$9K Buy
+40
New +$9K ﹤0.01% 5449